Literature DB >> 23030762

Optimization of a natural product-based class of γ-secretase modulators.

Jed L Hubbs1, Nathan O Fuller, Wesley F Austin, Ruichao Shen, Steffen P Creaser, Timothy D McKee, Robyn M B Loureiro, Barbara Tate, Weiming Xia, Jeffrey Ives, Brian S Bronk.   

Abstract

A series of triterpene-based γ-secretase modulators is optimized. An acetate present at the C24 position of the natural product was replaced with either carbamates or ethers to provide compounds with better metabolic stability. With one of those pharmacophores in place at C24, morpholines or carbamates were installed at the C3 position to refine the physicochemical properties of the analogues. This strategy gave compounds with low clearance and good distribution into the central nervous system (CNS) of CD-1 mice. Two of these compounds, 100 and 120, were tested for a pharmacodynamic effect in the strain and lowered brain Aβ42 levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030762     DOI: 10.1021/jm300976b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  γ-Secretase inhibitors and modulators.

Authors:  Todd E Golde; Edward H Koo; Kevin M Felsenstein; Barbara A Osborne; Lucio Miele
Journal:  Biochim Biophys Acta       Date:  2013-06-17

Review 2.  Development and mechanism of γ-secretase modulators for Alzheimer's disease.

Authors:  Christina J Crump; Douglas S Johnson; Yue-Ming Li
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

3.  Steroids as γ-secretase modulators.

Authors:  Joo In Jung; Thomas B Ladd; Thomas Kukar; Ashleigh R Price; Brenda D Moore; Edward H Koo; Todd E Golde; Kevin M Felsenstein
Journal:  FASEB J       Date:  2013-05-28       Impact factor: 5.191

Review 4.  Structural and Chemical Biology of Presenilin Complexes.

Authors:  Douglas S Johnson; Yue-Ming Li; Martin Pettersson; Peter H St George-Hyslop
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

5.  Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator.

Authors:  Joo In Jung; Ashleigh R Price; Thomas B Ladd; Yong Ran; Hyo-Jin Park; Carolina Ceballos-Diaz; Lisa A Smithson; Günther Hochhaus; Yufei Tang; Rajender Akula; Saritha Ba; Edward H Koo; Gideon Shapiro; Kevin M Felsenstein; Todd E Golde
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

Review 6.  The γ-secretase complex: from structure to function.

Authors:  Xian Zhang; Yanfang Li; Huaxi Xu; Yun-Wu Zhang
Journal:  Front Cell Neurosci       Date:  2014-12-11       Impact factor: 5.505

Review 7.  Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer's: a Comprehensive Review.

Authors:  Sedigheh Eskandari; Soraya Sajadimajd; Loghman Alaei; Zhaleh Soheilikhah; Hossein Derakhshankhah; Gholamreza Bahrami
Journal:  Neurotox Res       Date:  2021-06-25       Impact factor: 3.911

8.  γ-Secretase Modulators: Can We Combine Potency with Safety?

Authors:  Harrie J M Gijsen; Marc Mercken
Journal:  Int J Alzheimers Dis       Date:  2012-12-17

9.  Modulation of gamma-secretase for the treatment of Alzheimer's disease.

Authors:  Barbara Tate; Timothy D McKee; Robyn M B Loureiro; Jo Ann Dumin; Weiming Xia; Kevin Pojasek; Wesley F Austin; Nathan O Fuller; Jed L Hubbs; Ruichao Shen; Jeff Jonker; Jeff Ives; Brian S Bronk
Journal:  Int J Alzheimers Dis       Date:  2012-12-19

10.  Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models.

Authors:  Robyn M Loureiro; Jo Ann Dumin; Timothy D McKee; Wesley F Austin; Nathan O Fuller; Jed L Hubbs; Ruichao Shen; Jeff Jonker; Jeff Ives; Brian S Bronk; Barbara Tate
Journal:  Alzheimers Res Ther       Date:  2013-04-18       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.